公开(公告)号：US08163746B2

公开(公告)日：2012-04-24

申请号：US12297275

申请日：2007-04-19

申请人： Keizo Sugasawa ,  Kenichi Kawaguchi ,  Takaho Matsuzawa ,  Ryushi Seo ,  Hironori Harada ,  Akira Suga ,  Tomoaki Abe ,  Hidenori Azami ,  Shunichiro Matsumoto ,  Takashi Shin ,  Masayuki Tanahashi ,  Toru Watanabe

发明人： Keizo Sugasawa ,  Kenichi Kawaguchi ,  Takaho Matsuzawa ,  Ryushi Seo ,  Hironori Harada ,  Akira Suga ,  Tomoaki Abe ,  Hidenori Azami ,  Shunichiro Matsumoto ,  Takashi Shin ,  Masayuki Tanahashi ,  Toru Watanabe

IPC分类号： A61K31/5355 ,  A61K31/496 ,  A61K31/451 ,  A61K31/4535 ,  A61K31/426 ,  C07D413/14 ,  C07D211/32 ,  C07D211/46 ,  C07D277/24

CPC分类号： C07D277/56 ,  C07D263/34 ,  C07D263/48 ,  C07D413/04 ,  C07D413/12 ,  C07D413/14 ,  C07D417/04 ,  C07D417/12 ,  C07D417/14 ,  C07D471/04 ,  C07D471/10 ,  C07D487/08 ,  C07D491/08

摘要： Provided is an agent for treating or preventing urinary frequency, urinary urgency and urinary, incontinence which are associated with overactive bladder, a lower urinary tract disease such as interstitial cystitis and chronic prostatitis accompanied by lower urinary tract pain, and various diseases accompanied by pain. A novel azolecarboxamide derivative in which an azole ring such as thioazole or oxazole is bonded to a benzene ring, pyridine ring or pyrimidine ring through carboxamide was confirmed to have a potent trkA receptor-inhibitory activity and found to be an agent for treating or preventing lower urinary tract disease and various diseases accompanied by pain, which is excellent in efficacy and safety, and thus the present invention was accomplished.

摘要翻译： 提供治疗或预防与膀胱过度活动相关的尿频，尿急和尿失禁的药物，诸如间质性膀胱炎的下尿路疾病和伴有下尿路疼痛的慢性前列腺炎以及伴有疼痛的各种疾病。 通过甲酰胺将唑环或吡唑环或吡啶环或吡啶环与吡唑或恶唑等唑类结合的新型偶氮甲酰胺衍生物被证实具有强的trkA受体抑制活性，被发现是用于治疗或预防较低 泌尿道疾病，伴有疼痛的各种疾病，其功效和安全性优异，从而完成了本发明。

公开(公告)号：US20090286766A1

公开(公告)日：2009-11-19

申请号：US12297275

申请日：2007-04-19

申请人： Keizo Sugasawa ,  Kenichi Kawaguchi ,  Takaho Matsuzawa ,  Ryushi Seo ,  Hironori Harada ,  Akira Suga ,  Tomoaki Abe ,  Hidenori Azami ,  Shunichiro Matsumoto ,  Takashi Shin ,  Masayuki Tanahashi ,  Toru Watanabe

发明人： Keizo Sugasawa ,  Kenichi Kawaguchi ,  Takaho Matsuzawa ,  Ryushi Seo ,  Hironori Harada ,  Akira Suga ,  Tomoaki Abe ,  Hidenori Azami ,  Shunichiro Matsumoto ,  Takashi Shin ,  Masayuki Tanahashi ,  Toru Watanabe

IPC分类号： A61K31/496 ,  C07D417/12 ,  C07D487/04 ,  C07D417/14 ,  C07D413/12 ,  C07D413/14 ,  A61K31/454 ,  A61K31/5377 ,  A61K31/551 ,  A61K31/55 ,  A61K31/541 ,  A61P13/00

CPC分类号： C07D277/56 ,  C07D263/34 ,  C07D263/48 ,  C07D413/04 ,  C07D413/12 ,  C07D413/14 ,  C07D417/04 ,  C07D417/12 ,  C07D417/14 ,  C07D471/04 ,  C07D471/10 ,  C07D487/08 ,  C07D491/08

摘要： Provided is an agent for treating or preventing urinary frequency, urinary urgency and urinary, incontinence which are associated with overactive bladder, a lower urinary tract disease such as interstitial cystitis and chronic prostatitis accompanied by lower urinary tract pain, and various diseases accompanied by pain. A novel azolecarboxamide derivative in which an azole ring such as thioazole or oxazole is bonded to a benzene ring, pyridine ring or pyrimidine ring through carboxamide was confirmed to have a potent trkA receptor-inhibitory activity and found to be an agent for treating or preventing lower urinary tract disease and various diseases accompanied by pain, which is excellent in efficacy and safety, and thus the present invention was accomplished.

摘要翻译： 本发明提供一种治疗或预​​防尿频，尿急，尿失禁，与膀胱过度活动，下尿路疾病如间质性膀胱炎和伴有下尿路疼痛的慢性前列腺炎以及伴有疼痛的各种疾病相关的尿失禁。 通过甲酰胺将唑环或吡唑环或吡啶环或吡啶环与吡唑或恶唑等唑类结合的新型偶氮甲酰胺衍生物被证实具有强的trkA受体抑制活性，被发现是用于治疗或预防较低 泌尿道疾病，伴有疼痛的各种疾病，其功效和安全性优异，从而完成了本发明。

公开(公告)号：US08304547B2

公开(公告)日：2012-11-06

申请号：US12739433

申请日：2008-10-23

申请人： Keizo Sugasawa ,  Kenichi Kawaguchi ,  Takaho Nomura ,  Shunichiro Matsumoto ,  Takashi Shin ,  Hidenori Azami ,  Tomoaki Abe ,  Akira Suga ,  Ryushi Seo ,  Masayuki Tanahashi ,  Toru Watanabe

发明人： Keizo Sugasawa ,  Kenichi Kawaguchi ,  Takaho Nomura ,  Shunichiro Matsumoto ,  Takashi Shin ,  Hidenori Azami ,  Tomoaki Abe ,  Akira Suga ,  Ryushi Seo ,  Masayuki Tanahashi ,  Toru Watanabe

IPC分类号： C07D211/68 ,  C07D221/20 ,  C07D491/20 ,  C07D413/14 ,  C07D239/09 ,  A61K31/535 ,  A61K31/505 ,  A61K31/44 ,  A61K31/445

CPC分类号： C07D263/34 ,  C07D263/48 ,  C07D277/20 ,  C07D277/56 ,  C07D401/14 ,  C07D403/12 ,  C07D407/12 ,  C07D413/04 ,  C07D413/12 ,  C07D413/14 ,  C07D417/04 ,  C07D417/12 ,  C07D417/14 ,  C07D491/08 ,  C07D491/107 ,  C07D491/113 ,  C07D491/20 ,  C07D495/04 ,  C07D498/10

摘要： [Object] To provide a therapeutic and/or prophylactic agent for urinary frequency, urinary urgency, and urinary incontinence associated with various lower urinary tract diseases including overactive bladder, various lower urinary tract diseases accompanied by lower urinary tract pain, such as interstitial cystitis, chronic prostatitis, and the like, and various diseases accompanied by pain, based on an excellent trkA receptor inhibitory action.[Means for Solution] A novel azolecarboxamide compound in which a thiazole ring or an oxazole ring is bonded to a benzene ring, a pyridine ring, a pyridazine ring, a thiophene ring, a pyrazole ring or a pyrrole ring through carboxamide, or a salt thereof is confirmed to have a potent trkA receptor inhibitory activity, and found to be capable of being used as a therapeutic and/or prophylactic agent which is excellent in efficacy and safety for urinary frequency, urinary urgency, and urinary incontinence associated with various lower urinary tract diseases including overactive bladder, various lower urinary tract diseases accompanied by lower urinary tract pain, such as interstitial cystitis, chronic prostatitis, and the like, and various diseases accompanied by pain, thereby completing the present invention.

摘要翻译： 本发明提供一种用于与各种下尿路疾病（包括膀胱过度活动症，伴有下尿路疼痛，诸如间质性膀胱炎等）的各种下尿路疾病相关的尿频，尿急和尿失禁的治疗和/或预防剂， 慢性前列腺炎等，以及伴有疼痛的各种疾病，基于优异的trkA受体抑制作用。 [解决方案]通过甲酰胺或其盐将噻唑环或恶唑环与苯环，吡啶环，哒嗪环，噻吩环，吡唑环或吡咯环结合的新型偶氮甲酰胺化合物 被证实具有强的trkA受体抑制活性，发现能够用作治疗和/或预防剂，其对于尿频，尿急和与各种下尿路相关的尿失禁的功效和安全性优异 包括膀胱活动过度，伴有尿路下下尿路疼痛的下尿路疾病，如间质性膀胱炎，慢性前列腺炎等多种疾病，伴有疼痛的各种疾病，从而完成本发明。

公开(公告)号：US20100249088A1

公开(公告)日：2010-09-30

申请号：US12739433

申请日：2008-10-23

申请人： Keizo Sugasawa ,  Kenichi Kawaguchi ,  Takaho Nomura ,  Shunichiro Matsumoto ,  Takashi Shin ,  Hidenori Azami ,  Tomoaki Abe ,  Akira Suga ,  Ryushi Seo ,  Masayuki Tanahashi ,  Toru Watanabe

发明人： Keizo Sugasawa ,  Kenichi Kawaguchi ,  Takaho Nomura ,  Shunichiro Matsumoto ,  Takashi Shin ,  Hidenori Azami ,  Tomoaki Abe ,  Akira Suga ,  Ryushi Seo ,  Masayuki Tanahashi ,  Toru Watanabe

IPC分类号： A61K31/4545 ,  C07D413/14 ,  C07D417/14 ,  A61P13/02 ,  A61P13/10 ,  A61K31/5377 ,  A61K31/55 ,  A61K31/551 ,  A61K31/553 ,  A61K31/397 ,  A61P13/00 ,  A61P13/08

CPC分类号： C07D263/34 ,  C07D263/48 ,  C07D277/20 ,  C07D277/56 ,  C07D401/14 ,  C07D403/12 ,  C07D407/12 ,  C07D413/04 ,  C07D413/12 ,  C07D413/14 ,  C07D417/04 ,  C07D417/12 ,  C07D417/14 ,  C07D491/08 ,  C07D491/107 ,  C07D491/113 ,  C07D491/20 ,  C07D495/04 ,  C07D498/10

摘要： [Object] To provide a therapeutic and/or prophylactic agent for urinary frequency, urinary urgency, and urinary incontinence associated with various lower urinary tract diseases including overactive bladder, various lower urinary tract diseases accompanied by lower urinary tract pain, such as interstitial cystitis, chronic prostatitis, and the like, and various diseases accompanied by pain, based on an excellent trkA receptor inhibitory action.[Means for Solution] A novel azolecarboxamide compound in which a thiazole ring or an oxazole ring is bonded to a benzene ring, a pyridine ring, a pyridazine ring, a thiophene ring, a pyrazole ring or a pyrrole ring through carboxamide, or a salt thereof is confirmed to have a potent trkA receptor inhibitory activity, and found to be capable of being used as a therapeutic and/or prophylactic agent which is excellent in efficacy and safety for urinary frequency, urinary urgency, and urinary incontinence associated with various lower urinary tract diseases including overactive bladder, various lower urinary tract diseases accompanied by lower urinary tract pain, such as interstitial cystitis, chronic prostatitis, and the like, and various diseases accompanied by pain, thereby completing the present invention.

摘要翻译： 本发明提供一种用于与各种下尿路疾病（包括膀胱过度活动症，伴有下尿路疼痛，诸如间质性膀胱炎等）的各种下尿路疾病相关的尿频，尿急和尿失禁的治疗和/或预防剂， 慢性前列腺炎等，以及伴有疼痛的各种疾病，基于优异的trkA受体抑制作用。 [解决方案]通过甲酰胺或其盐将噻唑环或恶唑环与苯环，吡啶环，哒嗪环，噻吩环，吡唑环或吡咯环结合的新型偶氮甲酰胺化合物 被证实具有强的trkA受体抑制活性，发现能够用作治疗和/或预防剂，其对于尿频，尿急和与各种下尿路相关的尿失禁的功效和安全性优异 包括膀胱活动过度，伴有尿路下下尿路疼痛的下尿路疾病，如间质性膀胱炎，慢性前列腺炎等多种疾病，伴有疼痛的各种疾病，从而完成本发明。

公开(公告)号：US20090312328A1

公开(公告)日：2009-12-17

申请号：US12297445

申请日：2007-08-09

申请人： Hideki Kubota ,  Susumu Toda ,  Issei Tsukamoto ,  Yuta Fukuda ,  Ryutaro Wakayama ,  Kazuki Ono ,  Toru Watanabe ,  Hidenori Azami

发明人： Hideki Kubota ,  Susumu Toda ,  Issei Tsukamoto ,  Yuta Fukuda ,  Ryutaro Wakayama ,  Kazuki Ono ,  Toru Watanabe ,  Hidenori Azami

IPC分类号： A61K31/18 ,  C07C311/21 ,  C07D213/56 ,  C07D239/26 ,  C07D295/155 ,  C07D241/08 ,  A61K31/222 ,  A61K31/195 ,  A61K31/44 ,  A61K31/4406 ,  A61K31/505 ,  A61K31/4965 ,  A61K31/5375 ,  A61P13/00

CPC分类号： C07C311/29 ,  A61K31/18 ,  A61K31/195 ,  A61K31/197 ,  A61K31/198 ,  A61K31/216 ,  A61K31/235 ,  A61K31/24 ,  A61K31/275 ,  A61K31/341 ,  A61K31/343 ,  A61K31/381 ,  A61K31/40 ,  A61K31/4015 ,  A61K31/404 ,  A61K31/415 ,  A61K31/4196 ,  A61K31/423 ,  A61K31/426 ,  A61K31/44 ,  A61K31/4402 ,  A61K31/4406 ,  C07C311/14 ,  C07C311/19 ,  C07C311/21 ,  C07C311/47 ,  C07C311/51 ,  C07C323/49 ,  C07C2601/02 ,  C07C2601/08 ,  C07C2601/14 ,  C07C2602/08 ,  C07C2602/10 ,  C07D207/27 ,  C07D207/325 ,  C07D209/08 ,  C07D213/40 ,  C07D213/68 ,  C07D213/70 ,  C07D213/79 ,  C07D213/89 ,  C07D215/12 ,  C07D217/06 ,  C07D231/12 ,  C07D237/08 ,  C07D239/26 ,  C07D241/12 ,  C07D249/08 ,  C07D263/32 ,  C07D263/58 ,  C07D277/20 ,  C07D277/28 ,  C07D277/36 ,  C07D295/12 ,  C07D307/52 ,  C07D307/81 ,  C07D333/20 ,  C07D333/34 ,  C07D333/38 ,  C07D333/40 ,  C07D333/58

摘要： [Object] A compound that can be used as an agent for treating a disease associated with an EP1 receptor, in particular, a lower urinary tract symptom.[Means for Solution] It was confirmed that a sulfonamide compound having an amide structure and characterized by a chemical structure in which a carbon atom in the amide bonds to the N atom in sulfonamide through lower alkylene, or a salt thereof, has a potent EP1 receptor antagonistic activity, accomplishing the present invention. Since the sulfonamide compound of the present invention or a pharmaceutically acceptable salt thereof has a potent EP1 receptor antagonistic activity, it is useful as an agent for treating a disease associated with an EP1 receptor, in particular, a lower urinary tract symptom.

摘要翻译： [对象]可用作治疗与EP1受体，特别是下尿路症状相关的疾病的药剂的化合物。 [溶液的方法]确认具有酰胺结构的磺酰胺化合物，其特征在于其中酰胺中的氨基与磺酰胺中的N原子通过低级亚烷基或其盐键合的化学结构具有有效的EP1 受体拮抗活性，完成本发明。 由于本发明的磺酰胺化合物或其药学上可接受的盐具有有效的EP1受体拮抗活性，因此可用作治疗与EP1受体，特别是下尿路症状相关的疾病的药剂。

公开(公告)号：US07973078B2

公开(公告)日：2011-07-05

申请号：US12297445

申请日：2007-08-09

申请人： Hideki Kubota ,  Susumu Toda ,  Issei Tsukamoto ,  Yuta Fukuda ,  Ryutaro Wakayama ,  Kazuki Ono ,  Toru Watanabe ,  Hidenori Azami

发明人： Hideki Kubota ,  Susumu Toda ,  Issei Tsukamoto ,  Yuta Fukuda ,  Ryutaro Wakayama ,  Kazuki Ono ,  Toru Watanabe ,  Hidenori Azami

IPC分类号： C07C303/00 ,  A01N41/06

CPC分类号： C07C311/29 ,  A61K31/18 ,  A61K31/195 ,  A61K31/197 ,  A61K31/198 ,  A61K31/216 ,  A61K31/235 ,  A61K31/24 ,  A61K31/275 ,  A61K31/341 ,  A61K31/343 ,  A61K31/381 ,  A61K31/40 ,  A61K31/4015 ,  A61K31/404 ,  A61K31/415 ,  A61K31/4196 ,  A61K31/423 ,  A61K31/426 ,  A61K31/44 ,  A61K31/4402 ,  A61K31/4406 ,  C07C311/14 ,  C07C311/19 ,  C07C311/21 ,  C07C311/47 ,  C07C311/51 ,  C07C323/49 ,  C07C2601/02 ,  C07C2601/08 ,  C07C2601/14 ,  C07C2602/08 ,  C07C2602/10 ,  C07D207/27 ,  C07D207/325 ,  C07D209/08 ,  C07D213/40 ,  C07D213/68 ,  C07D213/70 ,  C07D213/79 ,  C07D213/89 ,  C07D215/12 ,  C07D217/06 ,  C07D231/12 ,  C07D237/08 ,  C07D239/26 ,  C07D241/12 ,  C07D249/08 ,  C07D263/32 ,  C07D263/58 ,  C07D277/20 ,  C07D277/28 ,  C07D277/36 ,  C07D295/12 ,  C07D307/52 ,  C07D307/81 ,  C07D333/20 ,  C07D333/34 ,  C07D333/38 ,  C07D333/40 ,  C07D333/58

摘要： A compound that can be used as an agent for treating a disease associated with an EP1 receptor, in particular a lower urinary tract symptom. It was confirmed that a sulfonamide compound having an amide structure and characterized by a chemical structure in which a carbon atom in the amide bonds to the N atom in sulfonamide through lower alkylene, or a salt thereof, has a potent EP1 receptor antagonistic activity, accomplishing the present invention. Since the sulfonamide compound of the present invention or a pharmaceutically acceptable salt thereof has a potent EP1 receptor antagonistic activity, it is useful as an agent for treating a disease associated with an EP1 receptor, in particular, a lower urinary tract symptom.

摘要翻译： 可用作治疗与EP1受体相关疾病，特别是下尿路症状的药物的化合物。 证实具有酰胺结构的磺酰胺化合物，其特征在于其中酰胺中的碳原子与磺酰胺中的N原子通过低级亚烷基或其盐键合的化学结构具有有效的EP1受体拮抗活性，完成 本发明。 由于本发明的磺酰胺化合物或其药学上可接受的盐具有有效的EP1受体拮抗活性，因此可用作治疗与EP1受体，特别是下尿路症状相关的疾病的药剂。

公开(公告)号：US10428268B2

公开(公告)日：2019-10-01

申请号：US13522126

申请日：2010-12-28

申请人： Toshihiro Ise ,  Tetsu Kitamura ,  Toru Watanabe

发明人： Toshihiro Ise ,  Tetsu Kitamura ,  Toru Watanabe

IPC分类号： H01L51/50 ,  C09K11/06 ,  H01L51/00 ,  H05B33/14 ,  C07F15/00

摘要： A light emitting organic thin film including at least one compound represented by Formula (PQ-1) and at least one compound represented by Formula (BN-1). In Formula (PQ-1), each of Ra, Rb and Rc independently represents a hydrogen atom or an alkyl group, wherein any one of Ra, Rb and Rc represents a hydrogen atom and the remaining two represent an alkyl group. Each of R1 to R5 independently represents a hydrogen atom, an alkyl group, an aryl group, a fluorine atom or a cyano group. Each of Rx and Ry independently represents an alkyl group or a phenyl group. In Formula (BN-1), Ar1 represents an arylene group that may have a substituent Z. Ar2 represents a condensed hydrocarbyl group that may have a substituent Z. Each of R101 to R113 independently represents a phenyl group, or the like.

公开(公告)号：US20140239280A1

公开(公告)日：2014-08-28

申请号：US14238371

申请日：2012-08-06

申请人： Saki Takada ,  Yosuke Yamamoto ,  Toshihiro Ise ,  Tetsu Kitamura ,  Toru Watanabe ,  Wataru Sotoyama ,  Koji Takaku ,  Kimiatsu Nomura

发明人： Saki Takada ,  Yosuke Yamamoto ,  Toshihiro Ise ,  Tetsu Kitamura ,  Toru Watanabe ,  Wataru Sotoyama ,  Koji Takaku ,  Kimiatsu Nomura

IPC分类号： H01L51/00

CPC分类号： H01L51/0056 ,  C09K11/06 ,  C09K2211/1007 ,  C09K2211/1011 ,  C09K2211/1033 ,  C09K2211/1044 ,  C09K2211/1059 ,  C09K2211/1088 ,  C09K2211/1092 ,  H01L51/0052 ,  H01L51/0061 ,  H01L51/0071 ,  H01L51/0072 ,  H01L51/0073 ,  H01L51/0074 ,  H01L51/5012 ,  H01L51/5024 ,  H05B33/14

摘要： An organic electroluminescent element using a compound represented by the following general formula emits dark blue light and has a small change in the chromaticity during luminance modulation: wherein each of R1 to R8 represents a hydrogen atom or a substituent; A1 to A4 represent CR31 or N; L and X each independently represent any one of CR32R33, NR34, O, S, and SiR35R36; and each of R31 to R36 represents a hydrogen atom or a substituent.

摘要翻译： 使用由以下通式表示的化合物的有机电致发光元件发出深蓝色光，并且在亮度调制期间具有小的色度变化：其中R1至R8各自表示氢原子或取代基; A1至A4表示CR31或N; L和X各自独立地表示CR32R33，NR34，O，S和SiR35R36中的任一个; R 31〜R 36表示氢原子或取代基。

公开(公告)号：US08614349B2

公开(公告)日：2013-12-24

申请号：US11666240

申请日：2005-11-17

申请人： Koshiro Yokota ,  Tatsuo Yamaguchi ,  Toru Watanabe

发明人： Koshiro Yokota ,  Tatsuo Yamaguchi ,  Toru Watanabe

IPC分类号： C07C67/00 ,  C07C69/02

CPC分类号： C07C67/40 ,  B01J21/08 ,  B01J21/18 ,  B01J23/44 ,  B01J23/628 ,  B01J31/121 ,  B01J2231/70 ,  C07B41/00 ,  C07C27/12 ,  C07C29/50 ,  C07C45/33 ,  C07C45/38 ,  C07C45/39 ,  C07C67/39 ,  C07C69/54 ,  C07C69/14 ,  C07C69/06

摘要： The present invention provides a method for oxidizing a hydrocarbon, an alcohol or an aldehyde, which comprises: oxidizing a hydrocarbon, an alcohol or an aldehyde to an alcohol, an aldehyde, a carboxylic acid or a carboxylate ester corresponding thereto, in a liquid phase having: a region in which oxygen is substantially present; and a region in which oxygen is substantially absent, in the presence of a catalyst containing a palladium, wherein the region in which oxygen is substantially absent is 0.1 to 10% by volume with respect to a total of the region in which oxygen is substantially present and the region in which oxygen is substantially absent.

摘要翻译： 本发明提供了一种用于氧化烃，醇或醛的方法，其包括：将烃，醇或醛氧化成液相中的醇，醛，羧酸或与其对应的羧酸酯 具有：基本上存在氧的区域; 以及在含有钯的催化剂的存在下，基本上不存在氧的区域，其中基本上不存在氧的区域相对于基本上存在氧的区域的总和为0.1-10体积％ 和氧基本上不存在的区域。

公开(公告)号：US20130020559A1

公开(公告)日：2013-01-24

申请号：US13522202

申请日：2010-12-28

申请人： Tetsu Kitamura ,  Toru Watanabe ,  Toshihiro Ise

发明人： Tetsu Kitamura ,  Toru Watanabe ,  Toshihiro Ise

IPC分类号： H01L51/54 ,  H01L27/32

CPC分类号： C07D209/86 ,  C07D221/06 ,  C07D235/18 ,  C07D403/12 ,  C07D487/22 ,  C09K11/06 ,  C09K2211/1007 ,  C09K2211/1011 ,  C09K2211/1014 ,  C09K2211/1029 ,  H01L51/0054 ,  H01L51/0072 ,  H01L51/0085 ,  H01L51/0087 ,  H01L51/0094 ,  H01L51/5012 ,  H01L51/5268 ,  H05B33/10

摘要： Provided is an organic electroluminescence device including a pair of electrodes composed of an anode and a cathode, a light emitting layer between the electrodes and an organic layer which is adjacent to the light emitting layer between the light emitting layer and the cathode, on a substrate, and the light emitting layer contains at least one compound having a carbazole structure and the organic layer adjacent to the light emitting layer contains at least one hydrocarbon compound having a specific structure.

摘要翻译： 本发明提供一种有机电致发光元件，其包括由阳极和阴极构成的一对电极，电极之间的发光层和与发光层和阴极之间的发光层相邻的有机层，在基板上 并且发光层含有至少一种具有咔唑结构的化合物，并且与发光层相邻的有机层含有至少一种具有特定结构的烃化合物。